Navigation Links
Elekta's New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
Date:4/24/2008

ATLANTA and CHICAGO, April 24 /PRNewswire/ -- Elekta, a global leader in minimally invasive neurosurgery will feature its latest line of stereotactic solutions at the 76th Annual Meeting of the American Association of Neurological Surgeons' (AANS), April 26 - May 1 in Chicago, Illinois. Highlights include Leksell Gamma Knife(R) Perfexion(TM) and Elekta Axesse(TM), two stereotactic treatment solutions that are creating new possibilities for the most challenging cases.

Now in clinical use in twenty locations across North America, Leksell Gamma Knife Perfexion combines the proven precision of the revolutionary Leksell Gamma Knife, with a three hundred percent expansion in clinical reach to treat a wider range of targets faster and more efficiently than ever before. The system's unique geometric and dosimetric design simultaneously administers hundreds of beams of low-intensity radiation that converge to deliver a single, therapeutic dose of radiation with pin-point accuracy to the most difficult targets; while integrated treatment planning and delivery streamlines the radiosurgery process to treat even multiple brain lesions in a single automated procedure.

Fully optimized for neurosurgery, Elekta Axesse is ideally suited for stereotactic radiosurgery or radiotherapy of the spine and body, providing total treatment control with proven technology that minimizes time-on-table and maximizes treatment capacity. And with volumetric 3D imaging, six-degree patient positioning, and fine-resolution beam shaping of Elekta Axesse make it a versatile, crossover treatment solution for neuro-oncology.

"Elekta is committed to supporting the neurosurgeon by providing highly refined tools that support specific clinical objectives," says Joseph K. Jachinowski, President and CEO of Elekta North America. "Technology that is perfectly aligned to the physician and the case at hand naturally results in faster treatments, increased productivity, higher profitabilit
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...WHITEHOUSE STATION, N.J., Dec. 1 M... Food and Drug Administration (FDA) has approved Z...e 1100 mg capsules), for over-the-counter treatmen...eted over-the-counter by Schering-Plough HealthCar... of Merck & Co., Inc. Schering-Plough and Merc...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Latin Ameri...environment, market analysis, forecasts and growth...om/p0165648/Latin-American-Pharmaceutical-Market-O...forecasts-and-growth-opportunities.html ,, T...
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.... available in its catalogue: ,, The Future of ...Competitive Benchmarking, Product Pipeline and Dea...166817/The-Future-of-Oncology-Therapeutics---Marke...ct-Pipeline-and-Deals-Analysis.html ,, Summar...
Breaking Medicine Technology:FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3FDA Panel Weighs Approving HPV Vaccine for Males 56544 1FDA Panel Weighs Approving HPV Vaccine for Males 56544 2FDA Panel Weighs Approving HPV Vaccine for Males 56544 3Both Patients and Physicians Most Frequently Recall Roches Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 56539 1Both Patients and Physicians Most Frequently Recall Roches Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 56539 2Both Patients and Physicians Most Frequently Recall Roches Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign 56539 3New Special Edition Oreck 28R 29 Vacuum Helps Clean for the Cure 28R 29 56534 1New Special Edition Oreck 28R 29 Vacuum Helps Clean for the Cure 28R 29 56534 2New Special Edition Oreck 28R 29 Vacuum Helps Clean for the Cure 28R 29 56534 3
...Editor Medcompare.com ,According to a Novem...nited Nations Programme on HIV/AIDS) and the World...with HIV globally reached an estimated high of 40....hs caused by AIDS. The latest data from the Cente... people in the United States are now living with H...
...ng Editor , ,Medical conventions are challeng...veness of cold medicine and the gold standard in b...ards in cholesterol testing are the latest casualt...rol has been measured by a simple panel of high-de...sity lipoprotein cholesterol (LDL-C); good and bad...
Other Medicine Technology:Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal 2Low-Density Cholesterol Subfractions: Not all LDL-C Particles are Created Equal 3
(Date:12/2/2009)... Bringing in the New Year tradit...be better and take better self-care. What to do to...in the focus toward goals for 2010? It’s ea...ve safe skin care is the primary mission. It isn,t...database, a popular consumer guide to safe cosmeti...
(Date:12/2/2009)... Links Medical Products Inc., an...als and nursing homes, announces the opening of it... facility is located at 9247 Research Drive, Irvin...intains another facility in the Irvine Spectrum pl..., California. This most recent expansion reflects ...
(Date:12/2/2009)... myEMRchoice.com Enables Persona... Fort Washington, PA (PRWEB) De...to give consumers is to read their own medical rec...R), keeping control of personal medical records is...ton, PA based healthcare technology company has ad...
(Date:12/2/2009)... eCube Systems Achieves IBM Read...tend heritage applications to the mainframe and co... Houston, TX (PRWEB) December 2, 2009 --...pplication modernization, today announced that it ...NXTera™ high performance middleware. This m...
(Date:12/2/2009)... , SAN DIEGO, Dec. 2 ...nt at the 21st Annual Piper Jaffray Health Care Co...entation is scheduled to be webcast live and may b... of Gen-Probe,s website at www.gen-probe.com . Th...the event. ,, About Gen-Probe ,, Gen-Prob...
Breaking Medicine News(10 mins):Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: